Revolutionary Clinical Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Revolutionary Clinical Trials in Brazil

Revolutionary Clinical Trials in Brazil – Top CROs in Latin America

Brazil, a diverse and dynamic country known for its vibrant culture and natural beauty, is also making significant strides in healthcare research and innovation. With its robust healthcare system, world-class research institutions, and a large and diverse population, Brazil has become a hub for revolutionary clinical trials.

This blog explores the groundbreaking clinical trials taking place in Brazil, highlighting their potential to transform healthcare practices, improve patient outcomes, and contribute to the global advancement of medical knowledge.

Brazil’s Growing Importance in Clinical Trials

Brazil’s emergence as a key player in clinical trials can be attributed to several factors. Firstly, the country’s diverse population, encompassing various ethnicities and genetic backgrounds, provides an ideal setting for conducting trials with broader generalizability and applicability.

Additionally, Brazil has invested heavily in developing state-of-the-art research facilities and fostering collaboration between academia, industry, and government bodies. This synergy has created an environment conducive to cutting-edge clinical research.

Moreover, Brazil’s regulatory framework has evolved to streamline the trial approval process, ensuring adherence to rigorous safety and ethical standards while facilitating efficient trial execution. These factors have propelled Brazil to the forefront of clinical research, attracting global pharmaceutical companies and research organizations to collaborate on revolutionary trials.

Advancements in Precision Medicine

Revolutionary clinical trials in Brazil are embracing the principles of precision medicine, which involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors.

Researchers in Brazil are leveraging advancements in genomics, molecular diagnostics, and personalized therapies to develop innovative treatments for various diseases. By analyzing genetic variations and biomarkers, researchers can identify patient subgroups that may respond differently to specific treatments.

This approach improves treatment efficacy, minimizes adverse effects, and paves the way for personalized medicine. The integration of precision medicine in clinical trials in Brazil is transforming healthcare practices and setting new standards for patient-centered care.

Revolutionary Clinical Trials in Brazil

Revolutionary Clinical Trials in Brazil
Revolutionary Clinical Trials in Brazil

Addressing Tropical Diseases and Public Health Challenges

Brazil’s diverse ecosystem and tropical climate present unique opportunities and challenges in healthcare. Revolutionary clinical trials in Brazil focus on tackling tropical diseases such as dengue fever, Zika virus, malaria, and Chagas disease.

Researchers collaborate with international partners and local communities to develop effective vaccines, diagnostic tools, and treatment strategies for these diseases. By addressing the specific healthcare needs of tropical regions, Brazil is making significant contributions to global public health efforts.

These trials also emphasize community engagement, education, and capacity-building, promoting sustainable healthcare solutions and empowering local populations.

Innovations in Trial Design and Technology Adoption

Brazilian researchers are at the forefront of innovation in clinical trial design and technology adoption. Adaptive trial designs, for example, allow researchers to modify trial parameters in real-time based on accumulating data. This flexibility enables more efficient resource allocation, reduces trial duration, and accelerates the delivery of new treatments to patients.

Additionally, Brazil has embraced digital health technologies and telemedicine, enabling decentralized trials and remote monitoring. These technologies improve patient access, increase participation rates, and enhance data collection, leading to more robust and accurate results. By leveraging cutting-edge trial designs and technology, Brazil is revolutionizing the clinical trial landscape and advancing healthcare research.

Collaboration and Knowledge Exchange

Collaboration and knowledge exchange are fundamental to the success of revolutionary clinical trials in Brazil. The country actively fosters partnerships with international pharmaceutical companies, research institutions, and regulatory agencies.

These collaborations facilitate the exchange of expertise, resources, and funding, enabling the execution of large-scale trials and the acceleration of research progress. By combining global perspectives and local knowledge, Brazil is at the forefront of medical innovation, attracting investments and fostering a collaborative ecosystem that drives breakthroughs in healthcare research.


Revolutionary clinical trials in Brazil are propelling healthcare research and innovation forward. The country’s diverse population, commitment to precision medicine, focus on tropical diseases, adoption of innovative trial designs and technology, and collaborative approach are revolutionizing the clinical trial landscape.

Brazil’s contributions to precision medicine, advancements in tropical disease research, and innovative trial methodologies have the potential to reshape healthcare practices not only within the country but also globally.

As Brazil continues to foster collaborations, attract investments, and prioritize research and development, it solidifies its position as a leader in clinical trials, driving the transformation of healthcare and improving patient outcomes. Through these revolutionary trials, Brazil is paving the way for a more personalized, effective, and patient-centric approach to medicine.

Revolutionary Clinical Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Revolutionary Clinical Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Revolutionary Clinical Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Revolutionary Clinical Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Revolutionary Clinical Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Revolutionary Clinical Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Revolutionary Clinical Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Revolutionary Clinical Trials in Brazil

The Cohortias Team

Revolutionary Clinical Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Revolutionary Clinical Trials in Brazil

Network & Partnerships